| Literature DB >> 841812 |
R A Bhatti, P D Guinan, C F McKiel, I M Bush, G R Bruns, M J Flanagan, R J Ablin.
Abstract
Preliminary evidence is presented suggestive of antitumor immunity, cross reactive with allogeneic extracts from tumors of the same type, and serum-blocking factor(s), which appear to be specific to autologous tumor only, in patients with prostatic cancer employing the method of leukocyte adherence inhibition.Entities:
Mesh：
Substances：
Year: 1977 PMID： 841812 DOI： 10.1016/0090-4295(77)90357-0
Source DB: PubMed Journal: Urology ISSN： 0090-4295 Impact factor: 2.649